期刊文献+

人激肽释放酶-1在甲醇酵母中高水平表达、纯化与鉴定 被引量:1

High Level Expression, Purification and Characterization of Human Kallikrein-1 in Pichia pastoris
下载PDF
导出
摘要 将自肾脏cDNA中获得的人激肽释放酶-1(Human kallikrein1,hK1)基因插入到pPICZαA载体中,构建甲醇酵母分泌型表达载体pPICZα-hK1,该载体转化毕赤酵母(Pichia pastoris)宿主菌X33,通过提高YPD平板和培养液中抗生素Zeocin的浓度(500~700μg/mL),筛选能高水平表达重组人激肽释放酶-1(Recombinant human kallikrein1,rhK1)的Ppastoris工程菌株。在30L发酵罐中发酵的表达条件为30℃、pH6.0,诱导64h时,发酵上清中rhK1产量达到6500u/L(约1.25g/L)。表达的rhK1有N-型糖基化程度不同的两种类型,分别是分子量偏犬的rhK1-H和分子量略小的rhK1-L。通过苯基疏水作用、Cu2+螯合以及阴离子交换层析纯化,从每升发酵上清中可获得0.28g的rhK1-H和0.62g的rhK1-L,纯化的总得率约为72%,纯度不低于96%。到目前为止,该研究获得的rhK1产量高于其他研究者的结果。 Human kallikrein-1 (hK1) gene was cloned from kidney tissues cDNA, it was inserted into the plasmid pPICZαA, then the yeast expression vector pPICZα-hK1 was constructed. After transformed into Pichia pastoris host X33, high-level expression transformants were screened by escalating the concentration of Zeocin (from 500 to 700 μg/mL) of YPD plate and medium. When temperature was 30℃, pH 6.0 with induction duration of 64 hours in the 30 L fermenter, the highest yield can reach about 6500 u/L (1.25 g/L). The variation of glycosylation resulted in two kinds of molecules, i.e. rhK1 -H with a heavy molecular weight and rhK1-L with a light one. rhK1 was purified from the supernatant through Phenyl hydrophobic interaction, Cu2+-charged Chelating and Anion-exchange chromatography. 0.28 g rhK1-H and 0.62 g rhK1-L can be purified from one liter supernatant. The yield recovery was 72% with a purity of 〉96%. So far our yield of rhK1 is superior than known recombinant expression method reported by other researchers.
出处 《生物工程学报》 CAS CSCD 北大核心 2008年第7期1186-1193,共8页 Chinese Journal of Biotechnology
关键词 激肽释放酶 毕赤酵母 重组蛋白 S-2266生色底物 kallikrein, Pichia pastoris, recombinant protein, S-2266 substrate
  • 相关文献

参考文献18

  • 1陈渝春,李少林.人组织激肽释放酶[J].国外医学(生理病理科学与临床分册),2003,23(4):386-388. 被引量:1
  • 2Yousef GM, Obiezu CV, Luo LY, et al. Human tissue kallikreins: from gene structure to function and clinical applications. Adv in Clin Chem, 2005, 39:11-79.
  • 3Oshima K. A review on the development of Kallikrein (Kallidinogenase). Yakushigaku Zasshi, 1994, 29(3): 498-507.
  • 4Angermann A, Bergmann C, Appelhasn H. Cloning and expression of human salivary-gland kallikrein in E. coli. Biochem J, 1989, 262(3): 787-793.
  • 5Wang J, Chao JL, Chao L. Purification and characterization of recombinant tissue kallikrein from E. coli and yeast. Biochem J, 1991, 276: 63-71.
  • 6Georg Fertig, Hans Peter Rahn, Axel Angermann, et al. Biotechnological aspects of the production of human pro-kallikrein using the AcNPV-baculovirus-expression system. Cytotechnology, 1993, 11: 67-75.
  • 7Lu SH, Hsu YR, Lu IL, et al. Isolation and characterization of human tissue kallikrein produced in E. coli: biochemical comparison to the enzymatically inactive prokallikrein and methionyl kallikrein. Protein Expr Purif, 1996, 8(2): 215-226.
  • 8Lu SH, Hsu YR, Narhi OL, et al. Purification and characterization of human tissue prokallikrein and kallikrein isoforms expressed in Chinese hamster ovary cells. Protein Expr Purif, 1996, 8(2): 227-237.
  • 9Chan H, Springman EB, Clark JM, et al. Expression and characterization of human tissue kallikrein variants. Protein Expr & Purif, 1998, 12: 361-370.
  • 10李体远,杜珙,朱莹,黄瑞芳,陈德珩.人组织激肽释放酶成熟蛋白的纯化及活性分析[J].中国生物制品学杂志,2005,18(1):33-35. 被引量:1

二级参考文献40

  • 1杨化新,沈佳,刘金秀.电位滴定法测定胰激肽释放酶活力测试条件探讨[J].药物分析杂志,1994,14(2):9-12. 被引量:7
  • 2Phillips M I. Gene therapy for hypertension: the preclinical data.Hypertension, 2001,38:543 ~ 848.
  • 3Ponder K P. Systemic gene therapy for cardiovascular disease. Treads Cardiovasc Med, 1999,9(6) : 158 ~ 162.
  • 4Pachori A S, Huentelman M J, Francis S C, Gelband C H, Katovich MJ, Raizada M K. The future of hypertension therapy: sense, antisense,or nonsense? Hypertension, 2001,37 : 357 ~ 364.
  • 5Wolf W C, Yeshida H, Agata J, Chao L, Chao J. Human tissue kallikrein gene delivery attenuates hypertension, renal injury,andcardiac remodeling in chronic renal failure. Kidney Int, 2000,58(2) :730 ~ 739.
  • 6Dellalibera-Joviliano R, Reis M L, Donadi E A. Kinin system in lupus nephritis. Int Immunopharmacol, 2001,1(9-10) : 1889 ~ 1896.
  • 7Evans B A, Yun Z X, Close J A, et al. Structure and chromosomal localization of the human renal kallikrein gene. Biochemistry, 1988,27 (9) : 3124 -3129.
  • 8Ikeda K. Isolation and some properties of a trypsin inhibitor from Buck whear Grain. Agric Biol Chem, 1978, 42 (4) : 309 ~312.
  • 9Nakanishi K, Nomura K, Asada N, et al. Pharmaceutical Research, 1993, 24 (6): 575-591.
  • 10Zhang X Y, Qi z W, Luo C Q. Studies on multifunctional crystalline proteinase inhibitors farm arrowhead. Scientia Sinica,1979, 12 (12) : 1443 ~ 1454.

共引文献10

同被引文献21

  • 1杨建军,张昕泂,周洁,龚振,陶群,叶丹,汪世龙,鞠佃文.rhEPO-Fc融合蛋白的表达、纯化及质量研究[J].中国生物工程杂志,2007,27(6):6-9. 被引量:7
  • 2Yousef GM, Diamandis EP. An overview of the kallikrein gene families in humans and other species: emerging candidate tumor markers. Clin Biochem, 2003, 36(6): 443.
  • 3Fukushima D, Kitamura N, Nakanishi S. Nucleotide sequence of cloned cDNA for human pancreatic kallikrein. Biochemistry, 1985, 24(27): 8037-8043.
  • 4Barker AR, Shine J. Human kidney kallikrein: cDNA cloning and sequence analysis. DNA, 1985, 4(6): 445-450.
  • 5Chao J, Woodley C, Chao L, et al. Identification of tissue kallikrein in brain and in the cell-free translation product encoded by brain mRNA. J Biol Chem, 1983, 258(24): 15173-15178.
  • 6Nolly H, Scicli AG, Scicli G, et al. Characterization of a kininogenase from rat vascular tissue resembling tissue kallikrein. Circ Res, 1985, 56(6): 816-821.
  • 7Evans BA, Yun ZX, Close JA, et al. Structure and chromosomal localization of the human renal kallikrein gene. Biochemistry, 1988, 27(9): 3124-3129.
  • 8Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev, 1992, 44(1): 1-80.
  • 9Pesquero JB, Bader M. Molecular biology of the kallikrein-kinin system: from structure to function. Braz J Med Biol Res, 1998, 31(9): 1197-1203.
  • 10Campbell DJ. The kallikrein-kinin system in humans. Clin Exp Pharmacol Physiol, 2001, 28(12): 1060-1065.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部